CME Group Inc. (NASDAQ:CME) Shares Bought by The Manufacturers Life Insurance Company

The Manufacturers Life Insurance Company raised its holdings in CME Group Inc. (NASDAQ:CME - Free Report) by 7.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 246,608 shares of the financial services provider's stock after acquiring an additional 17,551 shares during the period. The Manufacturers Life Insurance Company owned approximately 0.07% of CME Group worth $57,270,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Coldstream Capital Management Inc. raised its stake in CME Group by 11.7% during the fourth quarter. Coldstream Capital Management Inc. now owns 5,111 shares of the financial services provider's stock worth $1,187,000 after purchasing an additional 537 shares during the period. Topsail Wealth Management LLC acquired a new position in CME Group in the fourth quarter valued at approximately $252,000. Van Den Berg Management I Inc. increased its stake in CME Group by 0.9% during the fourth quarter. Van Den Berg Management I Inc. now owns 21,185 shares of the financial services provider's stock worth $4,920,000 after acquiring an additional 179 shares during the last quarter. Integrated Wealth Concepts LLC lifted its stake in shares of CME Group by 30.4% in the 4th quarter. Integrated Wealth Concepts LLC now owns 2,429 shares of the financial services provider's stock valued at $564,000 after purchasing an additional 566 shares during the last quarter. Finally, Burling Wealth Partners LLC acquired a new stake in shares of CME Group during the 4th quarter worth about $5,833,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.

CME Group Stock Up 0.7 %

Shares of NASDAQ CME traded up $2.08 during midday trading on Tuesday, hitting $284.64. 368,877 shares of the company's stock were exchanged, compared to its average volume of 2,153,692. The firm's fifty day simple moving average is $262.03 and its 200-day simple moving average is $244.22. The company has a market cap of $102.57 billion, a PE ratio of 29.46, a P/E/G ratio of 6.76 and a beta of 0.45. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $285.20. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02.

CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share for the quarter, topping the consensus estimate of $2.61 by $0.19. The business had revenue of $1.64 billion during the quarter, compared to the consensus estimate of $1.56 billion. CME Group had a net margin of 57.52% and a return on equity of 13.62%. The company's revenue was up 10.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.50 EPS. Research analysts predict that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Friday, March 7th were paid a $1.25 dividend. This represents a $5.00 annualized dividend and a yield of 1.76%. The ex-dividend date of this dividend was Friday, March 7th. This is an increase from CME Group's previous quarterly dividend of $1.15. CME Group's dividend payout ratio is currently 50.30%.

Insider Transactions at CME Group

In related news, Director Larry G. Gerdes sold 2,000 shares of the firm's stock in a transaction dated Thursday, April 24th. The stock was sold at an average price of $264.10, for a total transaction of $528,200.00. Following the transaction, the director now owns 38,651 shares of the company's stock, valued at $10,207,729.10. This trade represents a 4.92 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Dennis Suskind sold 1,000 shares of the company's stock in a transaction that occurred on Tuesday, April 29th. The shares were sold at an average price of $271.28, for a total value of $271,280.00. Following the sale, the director now directly owns 2,915 shares of the company's stock, valued at approximately $790,781.20. This represents a 25.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 30,076 shares of company stock worth $7,670,976. Corporate insiders own 0.30% of the company's stock.

Analyst Ratings Changes

Several brokerages have recently commented on CME. Citigroup lowered shares of CME Group from a "buy" rating to a "neutral" rating and decreased their price objective for the stock from $255.00 to $250.00 in a report on Monday, January 6th. Piper Sandler upped their price target on CME Group from $275.00 to $283.00 and gave the stock an "overweight" rating in a research note on Tuesday, April 8th. JPMorgan Chase & Co. dropped their price objective on CME Group from $223.00 to $211.00 and set an "underweight" rating for the company in a research note on Thursday, April 24th. Bank of America increased their target price on CME Group from $200.00 to $219.00 and gave the stock an "underperform" rating in a research note on Wednesday, April 2nd. Finally, Oppenheimer lifted their target price on CME Group from $269.00 to $279.00 and gave the company an "outperform" rating in a research report on Friday, April 11th. Three investment analysts have rated the stock with a sell rating, seven have given a hold rating, five have given a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus target price of $256.80.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.